1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TUBGCP3 CTRPv2 pan-cancer AAC 0.18 7e-08
mRNA RASGEF1B CTRPv2 pan-cancer AAC 0.17 7e-08
mRNA ZNF33A CTRPv2 pan-cancer AAC 0.19 7e-08
mRNA PSMD12 CTRPv2 pan-cancer AAC -0.17 7e-08
mRNA ZNF227 CTRPv2 pan-cancer AAC 0.18 8e-08
mRNA HDLBP CTRPv2 pan-cancer AAC -0.18 8e-08
mRNA FXYD6 CTRPv2 pan-cancer AAC 0.18 8e-08
mRNA BOLA3 CTRPv2 pan-cancer AAC -0.17 8e-08
mRNA SHC2 CTRPv2 pan-cancer AAC 0.17 8e-08
mRNA SREBF2 CTRPv2 pan-cancer AAC 0.18 8e-08
Download CSV